Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain
- PMID: 9007511
- DOI: 10.1016/s0014-2999(96)00910-7
Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain
Abstract
We assessed the effects of chronic (21 day) administration of antipsychotic drugs on the density of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor in rat brain. We used two typical antipsychotic drugs, haloperidol and pimozide, and two atypical antipsychotic drugs, risperidone and clozapine. Antipsychotic drugs as a group significantly elevated the density of the AMPA receptor measured with an AMPA receptor agonist ([3H]AMPA), but not with an AMPA receptor antagonist, 6-cyano-7-nitro-quinoxaline-2,3-dione ([3H]CNQX). In all regions studied, the magnitude of the increase seen with chronic typical antipsychotic drugs was significantly greater than that seen with chronic atypical antipsychotic drugs. In frontal cortex and striatum, typical antipsychotics but not atypical antipsychotics elevated AMPA receptor binding over control. These findings suggest that antipsychotic drugs alter the agonist affinity of the AMPA receptor without altering the number of AMPA receptors. Typical antipsychotic drugs may be more potent in this effect than atypical antipsychotic drugs, especially in critical corticostriatal circuits.
Similar articles
-
Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.J Mol Neurosci. 2007;32(3):192-8. doi: 10.1007/s12031-007-0034-3. J Mol Neurosci. 2007. PMID: 17873364
-
Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression.Synapse. 1998 Mar;28(3):195-207. doi: 10.1002/(SICI)1098-2396(199803)28:3<195::AID-SYN2>3.0.CO;2-5. Synapse. 1998. PMID: 9488504
-
Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.Psychopharmacology (Berl). 1996 Dec;128(4):371-9. doi: 10.1007/s002130050147. Psychopharmacology (Berl). 1996. PMID: 8986008
-
Atypical antipsychotics: mechanism of action.Can J Psychiatry. 2002 Feb;47(1):27-38. Can J Psychiatry. 2002. PMID: 11873706 Review.
-
Which atypical antipsychotics are identified by screening tests?Clin Neuropharmacol. 1989 Jun;12(3):167-84. doi: 10.1097/00002826-198906000-00002. Clin Neuropharmacol. 1989. PMID: 2568176 Review.
Cited by
-
Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.Behav Pharmacol. 2012 Feb;23(1):66-79. doi: 10.1097/FBP.0b013e32834ecac4. Behav Pharmacol. 2012. PMID: 22157143 Free PMC article.
-
Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.Drugs. 2000 Jan;59(1):33-78. doi: 10.2165/00003495-200059010-00004. Drugs. 2000. PMID: 10718099 Review.
-
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.Neuropsychopharmacology. 2008 Feb;33(3):465-72. doi: 10.1038/sj.npp.1301444. Epub 2007 May 9. Neuropsychopharmacology. 2008. PMID: 17487227 Free PMC article. Clinical Trial.
-
Effects of risperidone on glutamate receptor subtypes in developing rat brain.Eur Neuropsychopharmacol. 2009 Feb;19(2):77-84. doi: 10.1016/j.euroneuro.2008.08.010. Epub 2008 Oct 9. Eur Neuropsychopharmacol. 2009. PMID: 18845422 Free PMC article.
-
Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.J Mol Neurosci. 2007;32(3):192-8. doi: 10.1007/s12031-007-0034-3. J Mol Neurosci. 2007. PMID: 17873364
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources